IEQ Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.71M | Buy |
130,860
+60,448
| +86% | +$2.18M | 0.03% | 440 |
|
2025
Q1 | $2.19M | Buy |
70,412
+27,597
| +64% | +$859K | 0.02% | 564 |
|
2024
Q4 | $1.09M | Buy |
42,815
+7,184
| +20% | +$183K | 0.01% | 642 |
|
2024
Q3 | $1.01M | Sell |
35,631
-4,942
| -12% | -$140K | 0.01% | 545 |
|
2024
Q2 | $1.07M | Sell |
40,573
-4,995
| -11% | -$132K | 0.01% | 463 |
|
2024
Q1 | $1.38M | Buy |
45,568
+6
| +0% | +$182 | 0.02% | 394 |
|
2023
Q4 | $1.28M | Sell |
45,562
-1,717
| -4% | -$48.2K | 0.02% | 372 |
|
2023
Q3 | $1.28M | Buy |
47,279
+167
| +0.4% | +$4.53K | 0.03% | 339 |
|
2023
Q2 | $1.45M | Sell |
47,112
-1,095
| -2% | -$33.7K | 0.03% | 320 |
|
2023
Q1 | $1.74M | Buy |
48,207
+2,631
| +6% | +$94.8K | 0.04% | 279 |
|
2022
Q4 | $1.8M | Sell |
45,576
-190
| -0.4% | -$7.51K | 0.05% | 259 |
|
2022
Q3 | $1.84M | Buy |
45,766
+191
| +0.4% | +$7.68K | 0.05% | 247 |
|
2022
Q2 | $1.92M | Sell |
45,575
-66
| -0.1% | -$2.78K | 0.06% | 212 |
|
2022
Q1 | $1.78M | Buy |
45,641
+29
| +0.1% | +$1.13K | 0.04% | 228 |
|
2021
Q4 | $1.82M | Sell |
45,612
-1,415
| -3% | -$56.4K | 0.04% | 213 |
|
2021
Q3 | $1.7M | Buy |
47,027
+1,466
| +3% | +$53K | 0.05% | 211 |
|
2021
Q2 | $1.87M | Sell |
45,561
-18
| -0% | -$738 | 0.05% | 184 |
|
2021
Q1 | $1.99M | Buy |
45,579
+29
| +0.1% | +$1.27K | 0.08% | 137 |
|
2020
Q4 | $2.28M | Buy |
+45,550
| New | +$2.28M | 0.1% | 117 |
|